Advertisement

Potential Applications of Cell Cycle Manipulation to Clinical Response

  • Eleanor E. R. Harris
  • Gary D. Kao
  • Ruth J. Muschel
  • W. Gillies McKenna
Part of the Cancer Treatment and Research book series (CTAR, volume 93)

Abstract

The central organization of cellular life is the highly regulated process of cellular growth and division known as the cell cycle. A normal cell exhibits an exquisitely regulated system of proliferation and differentiation. The cancer cell has escaped these regulatory constraints such that it is able to grow and proliferate without restriction. Understanding the mechanisms controlling the cell cycle in both normal cells and cancer cells may enable researchers to develop more specific anticancer therapies by targeting the abnormalities exhibited by the cancer cell. The cell may be in a state of quiescence or actively cycling. Certain populations of cells are terminally differentiated and no longer have the ability to cycle or proliferate. These various states are becoming more well understood. The cell cycle is composed of four phases: G1, the gap prior to replication; S, the synthetic phase; G2, the gap after replication; M, the mitotic phase leading to cell division. The cell cycle represents a series of discrete phases with a continuum of interdependent activity preparing for each ensuing phase

Keywords

Cell Cycle Cell Cycle Checkpoint Ataxia Telangiectasia Viral Oncoproteins Cell Cycle Delay 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pardee AB, Dubrow R, Hamlin JL, Kletzein RF. 1978. Animal cell cycle. Annu Rev Biochem 47:715–750.PubMedGoogle Scholar
  2. 2.
    Norbury C, Nurse P. 1992. Animal cell cycles and their control. Annu Rev Biochem 61:441–470.PubMedGoogle Scholar
  3. 3.
    Pardee AB. 1989. Gl events and regulation of cell proliferation. Science 246:603–608.PubMedGoogle Scholar
  4. 4.
    Ganguly T, Iliakis G. 1995. A cell-free assay using cytoplasmic cell extracts to study rejoining of radiation-induced DNA double-strand breaks in human cell nuclei. Int J Radiat Biol 68:447–457.PubMedGoogle Scholar
  5. 5.
    Laskey RA, Fairman MP, Blow JJ. 1989. S phase of the cell cycle. Science 246:609–613.PubMedGoogle Scholar
  6. 6.
    Maity A, McKenna WG, Muschel RJ. 1994. The molecular basis for cell cycle delays following ionizing radiation. Radiother Oncol 31:1–13.PubMedGoogle Scholar
  7. 7.
    Mclntosh JR, Koonce MP, “Mitosis”. 1989. Science 246:622–628.Google Scholar
  8. 8.
    Glotzer M, et al. 1991. Cyclin is degraded by the ubiquitin pathway. Nature 349:132–138.PubMedGoogle Scholar
  9. 9.
    DeVoto SH, et al. 1992. A cyclin A protein kinase complex possesses sequence specific DNA binding activity: p33cdk2 is a component of the E2F cyclin A binding complex. Cell 68:167–176.PubMedGoogle Scholar
  10. 10.
    Knoblich JA, Lerner CF. 1993. Synergistic action of Drosophila cyclins A and B during the G2-M transition. EMBO J 12:65–74.PubMedGoogle Scholar
  11. 11.
    Ohtsubo M, Roberts J. 1993. Cyclin dependent regulation of Gl in mammalian fibroblasts. Science 259:1908–1912.PubMedGoogle Scholar
  12. 12.
    Polyak K, et al. 1994. p27Kipl, a cyclin-CDK inhibitor, links transforming growth factor-β and contact inhibition cell cycle arrest. Genes Dev 8:9.PubMedGoogle Scholar
  13. 13.
    DeBondt, et al. 1993. Crystal structure of cyclin-dependent kinase 2. Nature 363:595–602.Google Scholar
  14. 14.
    Fisher RP, Morgan DO. 1994. A novel cyclin associates with MO15/CDK7 to form the CDK activating kinase. Cell 78:713–724.PubMedGoogle Scholar
  15. 15.
    Makela TP, et al. 1994. A cyclin associated with the CDK-activating kinase MO15. Nature 371:254–257.PubMedGoogle Scholar
  16. 16.
    Krek W, Nigg E. 1991. Differential phospho-rylation of vertebrate p34cdc2 kinase at the Gl/ S and G2/M transitions of the cell cycle: Identification of major phosphorylation sites. EMBO J 10:305–316.PubMedGoogle Scholar
  17. 17.
    McGowan CH, Russell P. 1993. Human Weel kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyrl5. EMBO J 12:75–85.PubMedGoogle Scholar
  18. 18.
    Morgan DO. 1995. Principles of CDK regulation. Nature 374:131–134.PubMedGoogle Scholar
  19. 19.
    Hatakeyama M, et al. 1994. The cancer cell and the cell cycle clock. CSH Symposium on Quantative Biology 59:1–10.Google Scholar
  20. 20.
    Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.PubMedGoogle Scholar
  21. 21.
    Whyte P. 1995. The retinoblastoma protein and its relatives. Semin Cancer Biol 6:83–90.PubMedGoogle Scholar
  22. 22.
    Ludlow JW, Skuse GR. 1995. Viral oncoprotein binding to pRb, p107, p130 and p300. Virus Res 35:113–121.PubMedGoogle Scholar
  23. 23.
    Vousden KH. 1995. Regulation of the cell cycle by viral oncoproteins. Semin Cancer Biol 6:109–116.PubMedGoogle Scholar
  24. 24.
    Terasima T, Tolmach LJ. 1963. Variations in several responses of HeLa cells to X-irradiation during the division cycle. Biophys J ••:11–13.PubMedGoogle Scholar
  25. 25.
    Weinert TA, Hartwell LH. 1988. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241: 317–322.PubMedGoogle Scholar
  26. 26.
    Hittelman WA, Pollard M. 1982. A comparison of the DNA and chromosome repair kinetics after γ; irradiation. Radiat Res 92:497–509.PubMedGoogle Scholar
  27. 27.
    Petersen LN, et al. 1995. Gene-specific and strand-specific DNA repair in the Gl and G2 phases of the cell cycle. Mol Cell Biol 15:3731–3737.PubMedGoogle Scholar
  28. 28.
    Wlodek D, Hittelman WN. 1988. The relationship of DNA and chromosome damage to survival of synchronized X-irradiated L5178Y cells. II. Repair. Radiat Res 115:566–575.PubMedGoogle Scholar
  29. 29.
    Kastan MB, et al. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311.PubMedGoogle Scholar
  30. 30.
    Fornace AJ, et al. 1989. Mammalian genes co-ordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 9:4196–4203.PubMedGoogle Scholar
  31. 31.
    Kastan MB, et al. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587–597.PubMedGoogle Scholar
  32. 32.
    Painter RB, Young BR. 1980. Radiosensitivity in ataxia-telangiectasia: A new explanation. Proc Natl Acad Sci USA 77:7315–7317.PubMedGoogle Scholar
  33. 33.
    Wang Y, Iliakis G. 1992. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc. Cancer Res 52:508–514.PubMedGoogle Scholar
  34. 34.
    Doll R, Peto R. 1981. The causes of cancer in the United States today. J Natl Cancer Inst 66:1192.Google Scholar
  35. 35.
    Biederman KA, et al. 1991. The scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double strand break repair. Proc Natl Acad Sci USA 88:1394–1397.Google Scholar
  36. 36.
    Liu VF, et al. 1995. Cell cycle checkpoints and repair of ionizing radiation damage. Stem Cells 13:117–128.PubMedGoogle Scholar
  37. 37.
    Weinert TA, Hartwell LH, 1988. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241: 317–322.PubMedGoogle Scholar
  38. 38.
    Weinert TA. 1992. Dual cell cycle checkpoints sensitive to chromosome replication and DNA damage in the budding yeast Saccharomyces cerevisiae, Radiat Res 132:141–143.PubMedGoogle Scholar
  39. 39.
    Sheldrick KS, Carr AM. 1993. Feedback controls and G2 checkpoint: Fission yeast as a model system. Bioassays 15:775–782.Google Scholar
  40. 40.
    Aitken A, et al. 1992. 14-3-3 proteins: A highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci 17:498–501.PubMedGoogle Scholar
  41. 41.
    Rowley R. 1992. Radiation-induced mitotic delay: A genetic characterization in the fission yeast. Radiation Res 132:144–152.PubMedGoogle Scholar
  42. 42.
    Rowley R, et al. 1992. The weel protein kinase is required for radiation-induced mitotic delay. Nature 356:353–355.PubMedGoogle Scholar
  43. 43.
    Murray AW, et al. 1989. The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature 339:280–286.PubMedGoogle Scholar
  44. 44.
    McKenna WG, et al. 1991. Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat Res 125: 283–287.PubMedGoogle Scholar
  45. 45.
    Su LN, Little JB. 1993. Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or simian virus 40 T-antigen. Radiat Res 133:73–79.PubMedGoogle Scholar
  46. 46.
    Pines J, Hunter T. 1989. Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58:833–846.PubMedGoogle Scholar
  47. 47.
    Maity A, et al. 1995. Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J 14:603–609.PubMedGoogle Scholar
  48. 48.
    Datta R, et al. 1992. Down-regulation of cell cycle control genes by ionizing radiation. Cell Growth Differ 3:637–644.PubMedGoogle Scholar
  49. 49.
    Muschel RJ, et al. 1993. Differential effect of ionizing radiation on expression of cyclin A and cyclin B in HeLa cells. Cancer Res 5:1128–1135.Google Scholar
  50. 50.
    Bernhard EJ, et al. 1994. Increased expression of cyclin Bl mRNA coincides with diminished G2-phase arrest in irradiated HeLa cells treated with staurosporine or caffeine. Radiat Res 140: 393–400.PubMedGoogle Scholar
  51. 51.
    Tobey RA. 1975. Different drugs arrest cells at a number of distinct stages in G2. Nature 254:245–247.PubMedGoogle Scholar
  52. 52.
    Sorenson CM, Eastman A. 1988. Influence of cis-diamminedichloroplatinum (II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient chines hamster ovary cells. Cancer Res 48:6703–6707.PubMedGoogle Scholar
  53. 53.
    Bell DF, et al. 1988. Kinetic effects of adriamycin and bleomycin on two osteosarcoma models. J Orthoped Res 6:51–57.Google Scholar
  54. 54.
    Lokeshwar BL, et al. 1995. Enhancement of radiation response of prostatic carcinoma by taxol: Therapeutic potential for late-stage malignancy. Anticancer Res 15:93–98.PubMedGoogle Scholar
  55. 55.
    Yoshida D, et al. 1994. Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Res 54:1415–1417.PubMedGoogle Scholar
  56. 56.
    Maio JJ, et al. 1995. Induction of G2 arrests and gene expression by 2-aminopurine in human U937 promonocyte-macrophage cells. Exp Cell Res 219:442–448.PubMedGoogle Scholar
  57. 57.
    Davidoff AN, Mendelow BV. 1992. Unexpected cytokinetic effects induced by puromycin include a G2 arrest, a metaphase-mitotic arrest and apoptosis. Leuk Res 16:1077–1085.PubMedGoogle Scholar
  58. 58.
    Smith PJ, et al. 1994. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells. Br J Cancer 70:914–921.PubMedGoogle Scholar
  59. 59.
    Lock RB, Ross WE. 1990. Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. Cancer Res 50:3761–3766.PubMedGoogle Scholar
  60. 60.
    Hennequin C, et al. 1994. Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V79 cells and HeLa cells. Cancer Res 54:1720–1728.PubMedGoogle Scholar
  61. 61.
    Walton ML 1993. Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 53:1853–1861.PubMedGoogle Scholar
  62. 62.
    Busse PM, Bose SK. 1978. The action of caffeine on X-irradiated HeLa cells. III. Enhancement of x-ray induced killing during G2 arrest. Radiat Res 76:292–307.PubMedGoogle Scholar
  63. 63.
    Kim SH, et al. 1992. Enhancement of radiation response on human carcinoma cells in culture by pentoxyphylline. Int J Radiat Oncol Biol Phys 25:61–65.Google Scholar
  64. 64.
    O’Connor PM, et al. 1993. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B/cdc2-kinase complexes differently. J Biol Chem 268:8298–8308.PubMedGoogle Scholar
  65. 65.
    Hofmann J, et al. 1994. The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents. Biochem Biophys Res Commun 199:937–943.PubMedGoogle Scholar
  66. 66.
    Bhuyan BK, et al. 1992. Adozelesin, a potent new alkylating agent: Cell-killing kinetics and cell-cycle effects. Cancer Chemother Pharmacol 30:348–354.PubMedGoogle Scholar
  67. 67.
    Baker WJ, et al. 1993. Toremifene enhances cell cycle block and growth inhibition by vinblastine in multidrug resistant breast cancer cells. Oncol Res 5:207–212.PubMedGoogle Scholar
  68. 68.
    Nelson WG, Kastan MB. 1994. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14:1815–1823.PubMedGoogle Scholar
  69. 69.
    Lee JM, Bernstein A. 1993. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90:5742–5746.PubMedGoogle Scholar
  70. 70.
    Kastan M, et al. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311.PubMedGoogle Scholar
  71. 71.
    Kuerbitz SJ, et al. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89:7491–7495.PubMedGoogle Scholar
  72. 72.
    O’Connor PM, et al. 1993. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt’s lymphoma cell lines. Cancer Res 53:4776–4780.PubMedGoogle Scholar
  73. 73.
    Mcllwrath AJ, et al. 1994. Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity. Cancer Res 54:3718–3722.Google Scholar
  74. 74.
    Clarke AR, et al. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849–852.PubMedGoogle Scholar
  75. 75.
    Kastan MB. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587–597.PubMedGoogle Scholar
  76. 76.
    Kearsey JM, et al. 1995. GADD45 is a nuclear cell cycle regulated protein which interacts with p21Cipl. Oncogene 11:1675–1683.PubMedGoogle Scholar
  77. 77.
    Chen CY, et al. 1994. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA 91: 2684–2688.PubMedGoogle Scholar
  78. 78.
    Harper JW, et al. 1993. The p21 cdk-interacting protein CIP1 is a potent inhibitor of Gl cyclin-dependent kinases. Cell 75:805–816.PubMedGoogle Scholar
  79. 79.
    Dulic V, et al. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced Gl arrest. Cell 76:1013–1023.PubMedGoogle Scholar
  80. 80.
    El-Deiry WS, et al. 1993. WAF1, a potential mediator of p53 suppression. Cell 75:817–825.PubMedGoogle Scholar
  81. 81.
    El-Deiry WS, et al. 1994. WAF1/CIP1 is induced in p53-mediated Gl arrest and apoptosis. Cancer Res 54:1169–1174.PubMedGoogle Scholar
  82. 82.
    Fan S, et al. 1994. p53 gene mutations are associated with decreased sensivity of human lymphoma cells to DNA damaging agents. Cancer Res 54:5824–5830.PubMedGoogle Scholar
  83. 83.
    Brugarolas J, et al. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552–557.PubMedGoogle Scholar
  84. 84.
    Li CY, et al. 1995. Potential role of WAF1/ CIPl/p21 as a mediator of TGF-β cyto-inhibitory effect. J Biol Chem 270:4971–4974.PubMedGoogle Scholar
  85. 85.
    Nagasawa H, et al. 1995. Relationship between radiation-induced Gl phase arrest and p53 function in human tumor cells. Cancer Res 55:1842–1846.PubMedGoogle Scholar
  86. 86.
    Little JB, et al. 1995. Absence of radiation-induced Gl arrest in two closely related human lymphoblast cell lines that differ in p53 status. J Biol Chem 270:11033–11036.PubMedGoogle Scholar
  87. 87.
    Russell KJ, et al. 1995. Abrogation of the G2 checkpoint results in differential radiosen-sitization of the Gl checkpoint-deficient and Gl checkpoint-competent cells. Cancer Res 55:1639–1642.PubMedGoogle Scholar
  88. 88.
    Powell SN, et al. 1995. Differential sensitiza-tion of p53-and p53+ cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res 55:1643–1648.PubMedGoogle Scholar
  89. 89.
    Paules RS, et al. 1995. Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res 55:1763–1773.PubMedGoogle Scholar
  90. 90.
    Dou OP, et al. 1995. Induction of a retin-oblastoma phosphatase activity by anticancer drugs accompanies p53-independent Gl arrest and apoptosis. Proc Natl Acad Sci USA 92:9019–9023.PubMedGoogle Scholar
  91. 91.
    Akinaga S, et al. 1993. Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C. Cancer Chemother Pharmacol 32:183–189.PubMedGoogle Scholar
  92. 92.
    Nomura K, et al. 1978. Effect of dibutyryl cAMP on cell cycle progression of rat brain tumor cells in vitro. In Vitro 14:174–179.Google Scholar
  93. 93.
    Bhuyan BK, et al. 1986. Cell cycle effects of prostaglandins Al, A2 and D2 in human and murine melanoma cells in culture. Cancer Res 46:1688–1693.PubMedGoogle Scholar
  94. 94.
    Donaldson KL, et al. 1994. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int J Cancer 57:847–855.PubMedGoogle Scholar
  95. 95.
    Jungnelius U, et al. 1994. Cell cycle dependent sensitivity of the human melanoma cells to melphalan is correlated with the activity and cellular concentration of glutathione transferases. Carcinogenesis 15:99–103.PubMedGoogle Scholar
  96. 96.
    Minderman H, et al. 1993. Cell cycle related uptake, retention and toxicity of idarubicin, daunorubicin and doxorubicin. Anticancer Res 13:1161–1165.PubMedGoogle Scholar
  97. 97.
    Laderoute KR, et al. 1994. Epidermal growth factor modifies cell cycle control in A431 human squamous carcinoma cells damaged by ionizing radiation. Cancer Res 54:1407–1411.PubMedGoogle Scholar
  98. 98.
    Uckun FM, et al. 1989. Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells. Int J Radia Oncol Biol Phys 16:415–435.Google Scholar
  99. 99.
    Wyllie AH, et al. 1980. Cell death: The significance of apoptosis. Int Rev Cytol 68:251–306.PubMedGoogle Scholar
  100. 100.
    Solary E, et al. 1994. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. Leuk Lymphoma 15:21–32.PubMedGoogle Scholar
  101. 101.
    Yonish-Rouach E, et al. 1993. p53-mediated cell death: Relationship to cell cycle control. Mol Cell Biol 13:1415–1423.PubMedGoogle Scholar
  102. 102.
    Ling CC, et al. 1995. Radiation-induced apoptosis: Effects of cell age and dose fractionation. Cancer Res 55:5207.PubMedGoogle Scholar
  103. 103.
    King KL, Cidlowski JA. 1995. Cell cycle and apoptosis: Common pathways to life and death. J Cell Biochem 58:175–180.PubMedGoogle Scholar
  104. 104.
    Reed JC. 1987. Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1–6.Google Scholar
  105. 105.
    Symonds H, et al. 1994. p53-dependent apoptosis in vivo: Impact of p53 inactivation on tumorigenesis. CSH Symposium on Quantitative Biology 59:247–257.Google Scholar
  106. 106.
    Canman CE, et al. 1995. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 9:600–611.PubMedGoogle Scholar
  107. 107.
    Lowe SW, et al. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957–967.PubMedGoogle Scholar
  108. 108.
    Ludlow JW, et al. 1993. Hypoxic stress induces reversible hypophosphorylation of pRb and reduction in cyclin A abundance independent of cell cycle progression. Oncogene 8:331–339.PubMedGoogle Scholar
  109. 109.
    Graeber TG, et al. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88–91.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Eleanor E. R. Harris
  • Gary D. Kao
  • Ruth J. Muschel
  • W. Gillies McKenna

There are no affiliations available

Personalised recommendations